Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
47.02
+1.02 (2.22%)
At close: Aug 19, 2026, 4:00 PM EDT
46.70
-0.32 (-0.68%)
After-hours: Aug 19, 2026, 7:30 PM EDT

Pulse Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,3549301,071674103439
Market Cap Growth
208.46%-13.12%58.86%553.77%-76.50%-27.42%
Enterprise Value
3,2598431,000633109409
Last Close Price
47.0213.7317.4112.242.7714.81

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2830.032658.43--147.32309.48
PB Ratio
33.4611.549.3215.20-45.8712.30
P/TBV Ratio
34.7612.049.6616.99-14.78

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2749.992408.93--156.14288.38

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.090.080.21-33.790.32
Net Debt / Equity Ratio
-0.95-0.91-0.95-0.79-6.59-0.49
Net Debt / EBITDA Ratio
1.150.971.980.83-0.260.28
Net Debt / FCF Ratio
1.551.352.991.06-0.310.32
Asset Turnover
0.010.00--0.010.03
Quick Ratio
9.2710.2311.746.6110.223.37
Current Ratio
9.6310.5311.886.7610.394.30
Return on Equity (ROE)
-78.49%-74.45%-67.31%-200.46%-349.89%-217.33%
Return on Assets (ROA)
-44.34%-42.37%-36.70%-39.75%-54.93%-82.44%
Return on Capital Employed (ROCE)
-80.00%-88.80%-46.00%-83.10%-80.80%-137.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.39%-7.82%-5.00%-6.26%-56.73%-14.51%
FCF Yield
-1.83%-5.85%-3.40%-4.92%-45.98%-12.43%
Buyback Yield / Dilution
-7.37%-15.41%-17.41%-46.56%-21.35%-20.29%
SEC Filings: 10-K · 10-Q